Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersHematology (Internal Medicine) Physician in Columbus, OH
NPI: 1003862236Primary Practice Location
OHIO STATE UNIVERSITY STATE HEALTH SYSTEM
1670 Upham Dr, Columbus, OH
Primary Employer
OSU Internal Medicine
wexnermedical.osu.edu
HQ Phone
Get M.D. Don's Phone NumberMobile
Get M.D. Don's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardOH State Medical License
OH State Medical License
2003 - 2027
VA State Medical License
1999 - 2004
American Board of Internal Medicine
Medical Oncology
Ohio State University Hospital
Fellowship • Hematology and Medical Oncology
2003 - 2006
University of Virginia Medical Center
Residency • Internal Medicine
1999 - 2003
Northeast Ohio Medical University
neomed.edu
Medical School
Until 1999
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 187 | 249 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 107 | 158 |
| 3 | 99441Physician telephone patient service, 5-10 minutes of medical discussion | 11 | 13 |
Interferon-γ Promotes Antibody-mediated Fratricide of Acute Myeloid Leukemia Cells.
Authors: John Byrd, James Blachly, Sumithira Vasu, William Carson
Publication Date: 2016-08-10
Lenalidomide and Vorinostat Maintenance after Autologous Transplantation in Multiple Myeloma: Long- Term Follow-Up.
Authors: Nidhi Sharma, Ashley Rosko, Yvonne Efebera, Srinivas Devarakonda, Naresh Bumma
Publication Date: 2019-07-24
Authors: Nidhi Sharma, Ashley Rosko, Srinivas Devarakonda, Elvira Umyarova, Naresh Bumma
Journal: Front Oncol
Publication Date: 2023-07-24
Lead Sponsor: NexImmune Inc.
Intervention / Treatment: BIOLOGICAL: Infusion of NEXI-001 T Cells
Lead Sponsor: Cogent Biosciences, Inc.
Collaborators: Seagen Inc.
Intervention / Treatment: BIOLOGICAL: SEA-BCMA, BIOLOGICAL: ACTR087
Lead Sponsor: Takeda
Intervention / Treatment: DRUG: Dexamethasone, DRUG: Modakafusp alfa
